Urgent ethical need
There is an urgent ethical need for fast-acting pain relief for use during animal surgical procedures.
- Globally, over one billion farm animals undergo highly invasive painful surgical procedures annually (castration, dehorning, tail docking)
- Billions of farm animals also undergo less invasive procedures such as de-beaking in chickens
- Tens of millions of animals suffer from leg and shoulder ulcers, foot abscesses, accidental wounds and painful skin irritations
- Currently, a large majority of procedures are performed by a vet or farmer without analgesics
- The global number of livestock in 2017 was 26 billion, this is expected to reach 39 billion by 2030
- There is global pressure, supported by governments and non-governmental organisations, to provide pain relief alongside surgical procedures on animals
We are the first, and currently the only, company globally to develop, launch and commercialise a topical pain and wound management product for use in livestock undergoing painful husbandry procedures – Tri-Solfen® is recognised as the only safe, practical and efficient product for use on such wounds.
Development and application
Our product is successfully being used to improve animal welfare
Since launch, Tri-Solfen® has been used to successfully treat over 80 million animals undergoing routine surgeries in the Australian livestock industries.
- 2004, Tri-Solfen® developed by Dr Meredith Sheil, Medical Ethics’ Chief Technical Officer
- 2005, Tri-Solfen® approved for use in sheep in Australia
- 2006, Tri-Solfen® launched in Australia by Bayer Animal Health
- 2013, Tri-Solfen® granted over-the-counter status expanding the potential distribution
- 2014, Tri-Solfen® approved for use in cattle in Australia
- 2017, commercial partnership with Dechra Pharmaceuticals to support the registration of Tri-Solfen® globally (excluding Australia and New Zealand)
- 2017, Tri-Solfen® approved for use in sheep and cattle in New Zealand
We are committed to continuing to deliver Tri-Solfen®, as a highly effective, safe, affordable and practical pain relief product, to prevent pain and minimise suffering associated with wounds in livestock and companion animals.
Future opportunities in animals include:
- Continue to secure global registrations for Tri-Solfen® in livestock surgical procedures
- Companion animals (traumatic wounds)
- Accidental trauma
- Animal emergency rescue
- Companion animals (surgical wounds)
- Illness / disease
- Laboratory setting